Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 8

1.

Efficacy and safety of an extended nevirapine regimen in infants of breastfeeding mothers with HIV-1 infection for prevention of HIV-1 transmission (HPTN 046): 18-month results of a randomized, double-blind, placebo-controlled trial.

Fowler MG, Coovadia H, Herron CM, Maldonado Y, Chipato T, Moodley D, Musoke P, Aizire J, Manji K, Stranix-Chibanda L, Fawzi W, Chetty V, Msweli L, Kisenge R, Brown E, Mwatha A, Eshleman SH, Richardson P, Allen M, George K, Andrew P, Zwerski S, Mofenson LM, Jackson JB; HPTN 046 Protocol Team.

J Acquir Immune Defic Syndr. 2014 Mar 1;65(3):366-74. doi: 10.1097/QAI.0000000000000052.

2.

Familial renal cancer as an indicator of hereditary leiomyomatosis and renal cell cancer syndrome.

Raymond VM, Herron CM, Giordano TJ, Gruber SB.

Fam Cancer. 2012 Mar;11(1):115-21. doi: 10.1007/s10689-011-9485-3.

PMID:
22127509
3.

AXIN2-associated autosomal dominant ectodermal dysplasia and neoplastic syndrome.

Marvin ML, Mazzoni SM, Herron CM, Edwards S, Gruber SB, Petty EM.

Am J Med Genet A. 2011 Apr;155A(4):898-902. doi: 10.1002/ajmg.a.33927. Epub 2011 Mar 17.

4.
5.

Smoking, gender, and ethnicity predict somatic BRAF mutations in colorectal cancer.

Rozek LS, Herron CM, Greenson JK, Moreno V, Capella G, Rennert G, Gruber SB.

Cancer Epidemiol Biomarkers Prev. 2010 Mar;19(3):838-43. doi: 10.1158/1055-9965.EPI-09-1112. Epub 2010 Mar 3.

6.

Citrus tristeza virus transmission by the Toxoptera citricida vector: in vitro acquisition and transmission and infectivity immunoneutralization experiments.

Herron CM, Mirkov TE, da Graça JV, Lee RF.

J Virol Methods. 2006 Jun;134(1-2):205-11. Epub 2006 Feb 21.

PMID:
16490262
7.

Severity of Citrus tristeza virus Isolates from Texas.

Herron CM, Mirkov TE, N Solís-Gracia N, Kahlke CJ, Skaria M, da Graça JV.

Plant Dis. 2005 Jun;89(6):575-580. doi: 10.1094/PD-89-0575.

PMID:
30795381
8.

Bringing healthcare home.

Herron CM.

Health Prog. 1988 Jan-Feb;69(1):48-51.

PMID:
10285426

Supplemental Content

Loading ...
Support Center